Mice heterozygous for Wnt5a develop chronic myeloid leukaemia or B-cell disorders, while the analysis of 10 AML samples revealed deletion of the WNT5A gene and/or loss of WNT5A expression in a fraction of samples. The gene discussed is WNT5A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.